SCHEMBL600822

SCHEMBL600822

COc1c2ccccc2c(OC)c2cc(S(=O)(=O)OC)ccc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.52
KDM4E B2RXH2 2/20 0.52
ALDH1A1 P00352 1/20 0.52
MAPK1 P28482 1/20 0.52
TUBB4A P04350 2/20 0.44
TUBB P07437 2/20 0.44
TUBA3C P0DPH7 2/20 0.44
TUBA1B P68363 2/20 0.44
TUBA4A P68366 2/20 0.44
TUBB4B P68371 2/20 0.44
TUBB3 Q13509 2/20 0.44
TUBB2A Q13885 2/20 0.44
TUBB8 Q3ZCM7 2/20 0.44
TUBA3E Q6PEY2 2/20 0.44
TUBA1A Q71U36 2/20 0.44
TUBA1C Q9BQE3 2/20 0.44
TUBB6 Q9BUF5 2/20 0.44
TUBB2B Q9BVA1 2/20 0.44
TUBB1 Q9H4B7 2/20 0.44
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30043755 1.00 SMN1; SMN2 (0.52) SMN1; SMN2KDM4EALDH1A1MAPK1TUBB4A
SCHEMBL4617722 0.92 ALDH1A1 (0.44) SMN1; SMN2KDM4EALDH1A1MAPK1TUBB4A
SCHEMBL21247472 0.90 ALDH1A1 (0.42) SMN1; SMN2KDM4EALDH1A1MAPK1TUBB4A
SCHEMBL3838573 0.87 SMN1; SMN2 (0.48) SMN1; SMN2KDM4EALDH1A1MAPK1TUBB4A
SCHEMBL601854 0.84 GAA (0.40) SMN1; SMN2ALDH1A1MAPK1TUBB4ATUBB
SCHEMBL30043696 0.84 GAA (0.40) SMN1; SMN2ALDH1A1MAPK1TUBB4ATUBB
SCHEMBL4022680 0.83 SMN1; SMN2 (0.44) SMN1; SMN2KDM4EALDH1A1MAPK1TUBB4A
SCHEMBL8588357 0.83 ALDH1A1 (0.52) SMN1; SMN2KDM4EALDH1A1MAPK1TUBB4A
SCHEMBL2858129 0.83 KDM4E (0.52) SMN1; SMN2KDM4EALDH1A1MAPK1TUBB4A
SCHEMBL29868203 0.83 ALDH1A1 (0.52) SMN1; SMN2KDM4EALDH1A1MAPK1TUBB4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11635688-B2 Photoimageable compositions and processes for fabrication of relief patterns on low surface energy substrates KAYAKU ADVANCED MATERIALS, INC. (US) 2023-04-25 US claimed
US-20150024326-A1 PHOTOIMAGEABLE COMPOSITIONS AND PROCESSES FOR FABRICATION OF RELIEF PATTERNS ON LOW SURFACE ENERGY SUBSTRATES KAYAKU ADVANCED MATERIALS, INC. 2015-01-22 US claimed
WO-2013134104-A2 PHOTOIMAGEABLE COMPOSITIONS AND PROCESSES FOR FABRICATION OF RELIEF PATTERNS ON LOW SURFACE ENERGY SUBSTRATES MICROCHEM CORP. (US) 2013-09-12 WO claimed
WO-2025041519-A1 PHOTOSENSITIVE RESIN COMPOSITION AND CURED PRODUCT OF SAME 日本化薬株式会社 2025-02-27 WO disclosed
US-12189291-B2 Epoxy formulations and processes for fabrication of relief patterns on low surface energy substrates KAYAKU ADVANCED MATERIALS, INC. (US) 2025-01-07 US disclosed
US-20240168380-A1 Photosensitive Resin Composition And Cured Product Therefrom NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2024-05-23 US disclosed
US-11809078-B2 Photosensitive resin composition, dry film resist, and cured objects obtained therefrom NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2023-11-07 US disclosed
EP-2980058-B1 COMPOSITION CONTAINING VINYL-GROUP-CONTAINING COMPOUND TOKYO OHKA KOGYO CO LTD (JP) 2023-05-03 EP disclosed
US-11635688-B2 Photoimageable compositions and processes for fabrication of relief patterns on low surface energy substrates KAYAKU ADVANCED MATERIALS, INC. (US) 2023-04-25 US disclosed
CN-111217946-B Composition comprising a compound containing a vinyl group 东京应化工业株式会社 2022-12-06 CN disclosed
US-11142629-B2 Hydrogen barrier agent, hydrogen barrier film forming composition, hydrogen barrier film, method for producing hydrogen barrier film, and electronic element TOKYO OHKA KOGYO CO., LTD. (JP) 2021-10-12 US disclosed
CN-1914561-A Photoresist compositions and processess of use MICROCHEM CORP (US) 2007-02-14 CN disclosed
EP-1730592-A2 PERMANENT RESIST COMPOSITION, CURED PRODUCT THEREOF, AND USE THEREOF MicroChem Corp. (US) 2006-12-13 EP disclosed
EP-1706791-A2 PHOTORESIST COMPOSITIONS AND PROCESSESS OF USE MacroChem Corporation (US) 2006-10-04 EP disclosed
WO-2005079330-A2 PERMANENT RESIST COMPOSITION, CURED PRODUCT THEREOF, AND USE THEREOF MICROCHEM CORP. (US) 2005-09-01 WO disclosed
US-20050176982-A1 Method for producing onium salt derivatives, and novel onium salt derivatives TOYO GOSEI KOGYO CO., LTD. (JP) 2005-08-11 US disclosed
WO-2005067567-A2 PHOTORESIST COMPOSITIONS AND PROCESSESS OF USE MICROCHEM CORP. (US) 2005-07-28 WO disclosed
US-20050147918-A1 Photoresist compositions, hardened forms thereof, hardened patterns thereof and metal patterns formed using them MicroChem Corp. a corporation of the state of Massachusetts, US 2005-07-07 US disclosed
US-6620957-B1 Process for producing onium salt derivative and novel onium salt derivative TOYO GOSEI KOGYO CO., LTD. (JP) 2003-09-16 US disclosed
EP-1164127-A1 PROCESS FOR PRODUCING ONIUM SALT DERIVATIVE AND NOVEL ONIUM SALT DERIVATIVE Toyo Gosei Kogyo Co., Ltd. (JP) 2001-12-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050176982-A1 Method for producing onium salt derivatives, and novel onium salt derivatives STS, NANS, GRIK5 SMN1; SMN2 4269/4885KDM4E 2869/4885ALDH1A1 2710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.